Limitations	NNS	_
to	IN	_
the	DT	_
widespread	JJ	_
use	NN	_
of	IN	_
PET	NNP	_
arise	VBP	_
from	IN	_
the	DT	_
high	JJ	_
costs	NNS	_
of	IN	_
cyclotrons	NNS	_
needed	VBN	_
to	TO	_
produce	VB	_
the	DT	_
short	JJ	_
-	HYPH	_
lived	VBN	_
radionuclides	NNS	_
for	IN	_
PET	NNP	_
scanning	NN	_
and	CC	_
the	DT	_
need	NN	_
for	IN	_
specially	RB	_
adapted	VBN	_
on	IN	_
-	HYPH	_
site	NN	_
chemical	NN	_
synthesis	NN	_
apparatus	NN	_
to	TO	_
produce	VB	_
the	DT	_
radiopharmaceuticals	NNS	_
.	.	_

Few	JJ	CUE-1
hospitals	NNS	CUE-1
and	CC	CUE-1
universities	NNS	CUE-1
are	VBP	_
capable	JJ	_
of	IN	_
maintaining	VBG	_
such	JJ	_
systems	NNS	_
,	,	_
and	CC	_
most	JJS	CUE-2
clinical	JJ	CUE-2
PET	NN	CUE-2
is	VBZ	_
supported	VBN	_
by	IN	_
third	JJ	_
-	HYPH	_
party	NN	_
suppliers	NNS	_
of	IN	_
radiotracers	NNS	_
which	WDT	_
can	MD	_
supply	VB	_
many	JJ	CUE-3
sites	NNS	CUE-3
simultaneously	RB	_
.	.	_

This	DT	_
limitation	NN	_
restricts	VBZ	_
clinical	JJ	_
PET	NNP	_
primarily	RB	_
to	IN	_
the	DT	_
use	NN	_
of	IN	_
tracers	NNS	_
labelled	VBN	_
with	IN	_
F-18	NNP	_
,	,	_
which	WDT	_
has	VBZ	_
a	DT	_
half	JJ	_
life	NN	_
of	IN	_
110	CD	_
minutes	NNS	_
and	CC	_
can	MD	_
be	VB	_
transported	VBN	_
a	DT	_
reasonable	JJ	_
distance	NN	_
before	IN	_
use	NN	_
,	,	_
or	CC	_
to	IN	_
rubidium-82	NNP	_
,	,	_
which	WDT	_
can	MD	_
be	VB	_
created	VBN	_
in	IN	_
a	DT	_
portable	JJ	_
generator	NN	_
and	CC	_
is	VBZ	_
used	VBN	_
for	IN	_
myocardial	JJ	_
perfusion	NN	_
studies	NNS	_
.	.	_

Nevertheless	RB	_
,	,	_
in	IN	_
recent	JJ	_
years	NNS	_
a	DT	_
few	JJ	_
on	IN	_
-	HYPH	_
site	NN	_
cyclotrons	NNS	_
with	IN	_
integrated	VBN	_
shielding	VBG	_
and	CC	_
hot	JJ	_
labs	NNS	_
have	VBP	_
begun	VBN	_
to	TO	_
accompany	VB	_
PET	NNP	_
units	NNS	_
to	IN	_
remote	JJ	_
hospitals	NNS	_
.	.	_

